Innovita Biological Technology Co. Ltd. A (688253) — Capital Reinvestment Ratio
Innovita Biological Technology Co. Ltd. A (688253) has a Capital Reinvestment Ratio of 0.16x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥193.13 Million) in capital expenditures (CN¥31.13 Million). Check how tangible is Innovita Biological Technology Co. Ltd. 's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Innovita Biological Technology Co. Ltd. A Capital Reinvestment Ratio (2020–2025)
This chart tracks Innovita Biological Technology Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see Innovita Biological Technology Co. Ltd. cash conversion from operations.
Annual Capital Reinvestment Ratio for Innovita Biological Technology Co. Ltd. A (2020–2025)
Year-by-year Capital Reinvestment Ratio for Innovita Biological Technology Co. Ltd. A from 2020 to 2025. See Innovita Biological Technology Co. Ltd. (688253) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥193.13 Million | CN¥31.13 Million | ▲ +36.2% |
| 2024 | 0.12x | CN¥305.46 Million | CN¥36.16 Million | ▲ +81.3% |
| 2023 | 0.07x | CN¥259.85 Million | CN¥16.97 Million | ▼ -85.7% |
| 2022 | 0.46x | CN¥126.43 Million | CN¥57.71 Million | ▼ -23.9% |
| 2021 | 0.60x | CN¥106.27 Million | CN¥63.75 Million | ▲ +400.3% |
| 2020 | 0.12x | CN¥639.82 Million | CN¥76.71 Million | — |